Clinical Trial Update: Observational Study of Sifrol® in Patients With Primary Restless Legs Syndrome (RLS)

View source ↗

Summary

An observational study of Sifrol (pramipexole) in patients with primary restless legs syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Drugs mentioned

• Sifrol (ropinirole)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Restless Legs Syndrome | Status: COMPLETED